课题基金 / 基金详情

MOLECULAR PHYSIOLOGICAL MECHANISM OF AGERELATED CHANGES IN PRODUCTION OF NITRIC OXIDE AND PGI2

MOLECULAR PHYSIOLOGICAL MECHANISM OF AGERELATED CHANGES IN PRODUCTION OF NITRIC OXIDE AND PGI2
一氧化氮和 PGI2 产生年龄相关变化的分子生理机制
批准号:
11672254
负责人:
ISHIHATA Akira
金额:
$2.3万
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

ISHIHATA Akira的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
We demonstrated that several vasoconstricting peptides such as angiotensin II (AII) and endothelin-1 (ET-1) increased the production of nitric oxide (NO) and prostacyclin (PGI_2) in the rat hearts. Aging modulated the endothelial function to change the production of NO and PGI_2. It is implicated that PGI_2 plays an important role in the pathogenesis of hypertension, atherosclerosis and thrombosis due to its vasodilating and anti-platelet effect. We examined the age-related changes in the expression of enzymes responsible for the synthesis of PGI_2 and of PGI_2 receptors to reveal the mechanism of regulation of PGI_2 production. Aorta and hearts were isolated from 3-, and 27-months old Fischer 344 rats. Hearts were perfused with constant pressure (75 cmH_2O) at 37℃. Changes in the coronary flow were measured with a flow meter. 6-keto-PGF_1a in the coronary effluent was measured with EIA.Changes in the expression of PGI_2 receptors, PGI synthase and cyclooxygenase-1 (COX-1) were quantified by real-time PCR and Western blot analysis. Release of PGI_2 into the effluent was greater in the aged rat than young rat. There was no age-related difference in the amount of PGI_2 receptor. Expression of COX-1 and PGI synthase was increased in the aged rat. These increases in COX-1 and PGI synthase may be responsible for the increased production of PGI_2 in the aged rat coronary artery.
期刊论文(19)
专著(0)
科研奖励(0)
会议论文
Ishihata A, Katano Y, Nakamura M, Doi K, Tasaki K, Ono A: "Differential modulation of nitric oxide and prostacyclin release in senescent rat heart stimulated by angiotensin II."Eur J Pharmacol. 382. 19-26 (1999)
Ishihata A、Katano Y、Nakamura M、Doi K、Tasaki K、Ono A:“血管紧张素 II 刺激的衰老大鼠心脏中一氧化氮和前列环素释放的差异调节。”Eur J Pharmacol。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishihata A, Tezuka A, Ogaki T, Doi K, Katano Y: "Expression of COX-1, PGI synthase and PGI2 receptors in the aged rat aorta."J.Mol.Cell.Cardiol.. (in press).
Ishihata A、Tezuka A、Ogaki T、Doi K、Katano Y:“老年大鼠主动脉中 COX-1、PGI 合酶和 PGI2 受体的表达”。J.Mol.Cell.Cardiol..(出版中)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Katano Y, Ishihata A, Aita T, Ogaki T, Horie T: "Vasodilator effect of urotensin II, one of the most potent vasoconstricting factors, on rat coronary arteries."Eur.J.Pharmacol.. 402. R5-R7 (2000)
Katano Y、Ishihata A、Aita T、Ogaki T、Horie T:“尾加压素 II 的血管扩张作用,是最有效的血管收缩因子之一,对大鼠冠状动脉的作用。”Eur.J.Pharmacol.. 402. R5-R7 (2000
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Ishihata A, Katano Y, Ogaki T, Horie T, Doi K, Aita T: "Role of nitric oxide and cyclooxygenase products in the vascular effect of human urotensin II in the perfused rat heart."Free Radical Biol Med.. 29(supple 1). S70 (2000)
Ishihata A、Katano Y、Ogaki T、Horie T、Doi K、Aita T:“一氧化氮和环氧合酶产品在灌注大鼠心脏中人尾加压素 II 血管效应中的作用。”自由基生物医学.. 29(补充)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
17
    Progression of atherosclerosis in hypertriglyceridemic rabbit
    Involvement of urotensin II in the progression of atherosclerosis
    Role of Calcium ion in vascular smooth muscle and the alteration by aging.
    • 批准号:
      09670088
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.05万
    • 财政年份:
      1997
    • 负责人:
      ISHIHATA Akira
    • 依托单位:
    海外基金